Skip to main content
Toggle navigation
Menu
Overall search
Search ClinicalINFO
In affiliation with
HIV.gov
Search
Close
Main navigation
Home
About
Guidelines
Drug Database
Glossary
News
Resources
Contact Us
English
Toggle Dropdown
English
Español (Spanish)
Home
Search Results
Overall search
Search ClinicalINFO
Search Results
721 – 740
of
3979
Lenacapavir (Prevención del VIH)
https://clinicalinfo.hiv.gov/drugs/lenacapavir-hiv-prevention
Lenacapavir (HIV prevention)
https://clinicalinfo.hiv.gov/drugs/lenacapavir-hiv-prevention/health-professional
Tenofovir Alafenamide
https://clinicalinfo.hiv.gov/drugs/tenofovir-alafenamide/patient
Alafenamida de tenofovir
https://clinicalinfo.hiv.gov/drugs/tenofovir-alafenamide/patient
Tenofovir Alafenamide
https://clinicalinfo.hiv.gov/drugs/tenofovir-alafenamide/fda-label
Updated HHS Pediatric Antiretroviral Therapy Guidelines Released
https://clinicalinfo.hiv.gov/news/updated-hhs-pediatric-antiretroviral-therapy-guidelines-released
Se publican las guías actualizadas de la terapia antirretroviral pediátrica del HHS
https://clinicalinfo.hiv.gov/news/updated-hhs-pediatric-antiretroviral-therapy-guidelines-released
Clinicalinfo Releases Two New HIV-Related Drug Summaries: Lenacapavir and Vemlidy
https://clinicalinfo.hiv.gov/news/clinicalinfo-releases-two-new-hiv-related-drug-summaries-lenacapavir-and-vemlidy
Clinicalinfo publica dos nuevos resúmenes de medicamentos relacionados con el VIH: Lenacapavir y Vemlidy
https://clinicalinfo.hiv.gov/news/clinicalinfo-releases-two-new-hiv-related-drug-summaries-lenacapavir-and-vemlidy
Updated Medical Dictionary from Clinicalinfo Provides Definitions of HIV-related Terms
https://clinicalinfo.hiv.gov/news/updated-medical-dictionary-clinicalinfo-provides-definitions-hiv-related-terms
Diccionario médico actualizado de Clinicalinfo provee definiciones de términos relacionados con el VIH.
https://clinicalinfo.hiv.gov/news/updated-medical-dictionary-clinicalinfo-provides-definitions-hiv-related-terms
What to Start: Initial Combination Antiretroviral Regimens
https://clinicalinfo.hiv.gov/guidelines/hiv-clinical-guidelines-adult-and-adolescent-arv/what-start-initial-combination
What to Start: Protease Inhibitor–Based Regimens
https://clinicalinfo.hiv.gov/guidelines/hiv-clinical-guidelines-adult-and-adolescent-arv/what-start-protease-inhibitor-based
What to Start: Advantages and Disadvantages of Antiretroviral Components for Initial Therapy
https://clinicalinfo.hiv.gov/guidelines/hiv-clinical-guidelines-adult-and-adolescent-arv/what-start-advantages-and-disadvantages
What to Start: Other Antiretroviral Regimens When Abacavir and Tenofovir Cannot Be Used or Are Not Optimal
https://clinicalinfo.hiv.gov/guidelines/hiv-clinical-guidelines-adult-and-adolescent-arv/what-start-other-antiretroviral
What to Start: Initial Antiretroviral Therapy Based on Specific Clinical Scenarios
https://clinicalinfo.hiv.gov/guidelines/hiv-clinical-guidelines-adult-and-adolescent-arv/what-start-initial-antiretroviral
What to Start: Non-Nucleoside Reverse Transcriptase Inhibitor Regimens
https://clinicalinfo.hiv.gov/guidelines/hiv-clinical-guidelines-adult-and-adolescent-arv/what-start-non-nucleoside-reverse
What to Start: Integrase Strand Transfer Inhibitor Regimens
https://clinicalinfo.hiv.gov/guidelines/hiv-clinical-guidelines-adult-and-adolescent-arv/what-start-integrase-strand-transfer
What to Start: Nucleoside Reverse Transcriptase Inhibitor Options
https://clinicalinfo.hiv.gov/guidelines/hiv-clinical-guidelines-adult-and-adolescent-arv/what-start-nucleoside-reverse
Drug-Drug Interactions: HIV-1 gp120 Inhibitors and Other Drugs
https://clinicalinfo.hiv.gov/guidelines/hiv-clinical-guidelines-adult-and-adolescent-arv/drug-interactions-hiv-1-gp120-inhibitors
Pagination
First page
«
Previous page
‹
…
Page
33
Page
34
Page
35
Page
36
Current page
37
Page
38
Page
39
Page
40
Page
41
…
Next page
›
Last page
»